Utah Medical Products (UTMD) Revenue (2010 - 2026)

Utah Medical Products' Revenue history runs 17 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• On a quarterly basis, Revenue fell 10.18% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was $37.5 million, a 4.43% decrease from a year earlier, with the FY2025 full-year figure at $38.5 million, down 5.83% from the prior year.
• Revenue eased to $8.7 million in Q1 2026 per UTMD's latest filing, from $9.0 million in the prior quarter.
• Across five years, Revenue topped out at $13.6 million in Q4 2022 and bottomed at $8.7 million in Q1 2026.
• The 5-year median for Revenue is $11.3 million (2024), against an average of $11.2 million.
• Across the five-year window, Revenue grew 12.4% in 2022 and declined 25.75% in 2024, its largest moves.
• Year by year, Revenue stood at $13.6 million in 2022, then retreated by 9.15% to $12.3 million in 2023, then decreased by 25.75% to $9.2 million in 2024, then retreated by 1.23% to $9.0 million in 2025, then dropped by 3.56% to $8.7 million in 2026.
• Per Business Quant, the three latest UTMD Revenue figures stand at $8.7 million (Q1 2026), $9.0 million (Q4 2025), and $9.8 million (Q3 2025).